Latest Industry Insights

Technology Networks spoke with Dr. Mark Van Oene, chief operating officer at PacBio, about an ambitious population genomics effort – the Korean Pangenome Reference Project.

At this year’s American Society of Human Genetics (ASHG) meeting, Ultima Genomics drew attention for its ambitious goal of making large-scale omics research more accessible and affordable.

In this Q&A, Pratt discusses a recent study comparing multiplex droplet digital PCR (ddPCR) with traditional quantitative PCR (qPCR), highlighting key methodological differences, assay validation strategies and the advantages of ddPCR.

At ASHG, Illumina launches 5-base and shows exciting results from constellation, a breakthrough technology offering long-range genomic insights from unfragmented DNA.

Dr. Heidi Rehm shares insights on how genomics is evolving at the intersection of research and clinical practice. In this Q&A, she highlights the role of AI, global data standards and collaboration in shaping future patient care.

Families with rare diseases often wait years for answers. GeneDx’s AI-driven dataset, Infinity™, is changing that. In this interview, Dr. Bryan Dechario explains how decades of data are reshaping the future of genomic medicine.

In this interview, Dr. Eleonora Juarez explains how Oxford Nanopore’s new Hereditary Cancer Panel could streamline testing, expand access and influence future best practices in hereditary cancer workflows.

In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.

A recent milestone study used the LNP delivery system developed by Acuitas Therapeutics to treat a newborn with urea cycle disorder (UCD) successfully with a personalized CRISPR therapy. We spoke to Dr. Ying Tam, their CSO, to find out more.

AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.